LIMN
Liminatus Pharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.23
-0.01 ▼ -2.10%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$0.24
+0.00 +2.10%
| Index | - | P/E | - | EPS (ttm) | -0.19 | Insider Own | 79.47% | Shs Outstand | 0.03B | Perf Week | 0.34% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.01B | Perf Month | -60.98% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 0.81% | Short Float | 16.2% | Perf Quarter | -73.9% |
| Income | -0.00B | P/S | - | EPS this Y | - | Inst Trans | 4.18% | Short Ratio | 0.15 | Perf Half Y | -88.8% |
| Sales | 0.00B | P/B | - | EPS next 5Y | - | ROA | -116.93% | Short Interest | 1.31M | Perf YTD | -61.8% |
| Book/sh | -0.06 | P/C | 12.72 | EPS past 3/5Y | - | ROE | - | 52W High | -99.31% ($33.66) | Perf Year | -98.45% |
| Cash/sh | 0.02 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 10.95% ($0.21) | Perf 3Y | -97.76% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 46.82% | Gross Margin | - | Volatility(W/M) | 8.91% 15.69% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.12 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.42 | EPS Q/Q | 24.67% | Profit Margin | - | RSI (14) | 38.29 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.42 | Sales Q/Q | - | SMA20 | -5.85% ($0.24) | Beta | 0.5 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -62.06% ($0.61) | Rel Volume | 0.19 | Prev Close | $0.24 |
| Employees | 3 | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -93.52% ($3.55) | Avg Volume(3M) | 8.75M | Price | $0.23 |
| IPO | 2021/5/26 | Option/Short | No/Yes | Trades | 867 | Volume | 1,622,250 | Change | -2.1% |
뉴스 로딩 중...